| 1 |
35573043 | Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. | 2022 Jun 9 |
1 |
| 2 |
31890735 | Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice. | 2019 Dec 13 |
2 |
| 3 |
30496309 | Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model. | 2018 |
1 |
| 4 |
28351939 | Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. | 2017 May 11 |
1 |
| 5 |
22306296 | Maternal administration of busulfan before in utero transplantation of human hematopoietic stem cells enhances engraftments in sheep. | 2012 Jun |
1 |
| 6 |
12189531 | The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo. | 2002 Aug |
2 |
| 7 |
10881000 | Long-term results of CD34(+) cell transplantation in children with neuroblastoma. | 2000 Jul |
1 |
| 8 |
8547090 | CD34+ cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass. | 1995 Oct |
1 |